Filing Flows

Filing Flows › 8-K events › Glaukos

Glaukos: results of operations

Form 8-K filed Oct 28, 2026 · items 2.02, 7.01

Results of operationsGlaukos Announces Third Quarter 2026 Financial Results

What the filing says

Vice President, Investor Relations & Corporate Affairs Glaukos Announces Third Quarter 2026 Financial Results

Read the filing on SEC EDGAR →

What usually followsAcross 69,115 8-Ks reporting Item 2.02 (results of operations) in our universe, the stock's median move the next session was +0.2% (typical size ±3.6%, up 51% of the time); over the following 21 sessions, +1.2%. Every item ranked →

Glaukos at a glance

Latest quarterQ3 2026
Revenue$211.0M
Revenue Y/Y+58%
Operating margin0.4%
IndustrySurgical & Medical Instruments & Apparatus

Glaukos, Q3 2026: revenue $211M (+58% year over year), operating margin 0.4%. The chart follows the revenue to costs, profit and cash.

Glaukos: every quarter, Q/Q and Y/Y, holders and guidance →

Other recent guidance

Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.